IRX2-mediated upregulation of MMP-9 and VEGF in a PI3K/AKT-dependent manner

Liu,Tielong; Zhou,Weiwei; Cai,Bing; Chu,Jianjun; Shi,Guodong; Teng,Honglin; Xu,Jian; Xiao,Jianru; Wang,Yan

doi:10.3892/mmr.2015.3915

IRX2-mediated upregulation of MMP-9 and VEGF in a PI3K/AKT-dependent manner

Authors:
- Tielong Liu
- Weiwei Zhou
- Bing Cai
- Jianjun Chu
- Guodong Shi
- Honglin Teng
- Jian Xu
- Jianru Xiao
- Yan Wang
View Affiliations

Affiliations: Department of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China, Department of Radiology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China, Department of Orthopedics, Ningbo Development Zone Center Hospital, Ningbo, Zhejiang 315800, P.R. China, Department of Orthopedics, First People's Hospital of Hefei, Hefei, Anhui 230061, P.R. China, Department of Orthopedics, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China, Department of Orthopedics, The Workers Hospital of Suqian City, Suqian, Jiangsu 223800, P.R. China, Department of Orthopedics, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China
Published online on: June 11, 2015 https://doi.org/10.3892/mmr.2015.3915
Pages: 4346-4351

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteosarcoma (OS) is the most frequent type of primitive malignant bone tumor with a poor prognosis due to distant metastasis. Our previous studies have demonstrated that IRX2 is overexpressed and is important in cell proliferation and invasion. However, the molecular mechanisms underlying the IRX2‑dependent regulation of OS progression remains to be elucidated. In the present study, the effects of IRX2 on the upregulation of MMP2 and VEGF in OS were determined by western blotting, and the underlying molecular mechanisms were elucidated. These findings provided data suggesting that IRX2 modulates the expression levels of MMP2 and VEGF in an AKT‑dependent manner. The overexpression of IRX2 promoted the activation of PI3K/Akt and increased the proliferation and invasiveness of the OS cell lines as shown by CCK8 and invasion assays. Notably, interruption of the AKT pathway by treatment with LY294002, a specific PI3K inhibitor, attenuated IRX2‑induced cell proliferation and invasive ability, and the upregulation of MMP2 and VEGF. The results of the present study suggested that inhibition of the IRX2‑mediated AKT signaling pathway may be a suitable therapeutic target for the treatment of OS.

View Figures

View References

1	Picci P, Mercuri M, Ferrari S, et al: Survival in high-grade osteosarcoma: Improvement over 21 years at a single institution. Ann Oncol. 21:1366–1373. 2010. View Article : Google Scholar
2	Broadhead ML, Clark JC, Myers DE, Dass CR and Choong PF: The molecular pathogenesis of osteosarcoma: A review. Sarcoma. 2011:9592482011. View Article : Google Scholar : PubMed/NCBI
3	Cesari M, Alberghini M, Vanel D, et al: Periosteal osteosarcoma: A single-institution experience. Cancer. 117:1731–1735. 2011. View Article : Google Scholar : PubMed/NCBI
4	Thomas DM: Wnts, bone and cancer. J Pathol. 220:1–4. 2010. View Article : Google Scholar
5	Liu T, Zhou W, Zhang F, et al: Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway. Mol Med Rep. 10:169–174. 2014.PubMed/NCBI
6	Kadota M, Sato M, Duncan B, et al: Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA. Cancer Res. 69:7357–7365. 2009. View Article : Google Scholar : PubMed/NCBI
7	Adamowicz M, Radlwimmer B, Rieker RJ, et al: Frequent amplifications and abundant expression of TRIO, NKD2 and IRX2 in soft tissue sarcomas. Genes Chromosomes Cancer. 45:829–838. 2006. View Article : Google Scholar : PubMed/NCBI
8	Kang H, Wilson CS, Harvey RC, et al: Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: A Children's Oncology Group study. Blood. 119:1872–1881. 2012. View Article : Google Scholar : PubMed/NCBI
9	Sato T, Arai E, Kohno T, et al: Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease. Int J Cancer. 135:319–334. 2014. View Article : Google Scholar : PubMed/NCBI
10	Francipane MG and Lagasse E: mTOR pathway in colorectal cancer: An update. Oncotarget. 5:49–66. 2014.PubMed/NCBI
11	Pandurangan AK and Esa NM: Signal transducer and activator of transcription 3-a promising target in colitis-associated cancer. Asian Pac J Cancer Prev. 15:551–560. 2014. View Article : Google Scholar
12	Martini M, De Santis MC, Braccini L, Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: an updated review. Ann Med. 46:372–383. 2014. View Article : Google Scholar : PubMed/NCBI
13	Vivanco I and Sawyers CL: The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2:489–501. 2002. View Article : Google Scholar : PubMed/NCBI
14	Guo YS, Zhao R, Ma J, et al: βig-h3 promotes human osteosarcoma cells metastasis by interacting with integrin alpha2beta1 and activating PI3K signaling pathway. PLoS One. 9:e902202014. View Article : Google Scholar
15	Gong C, Liao H, Wang J, et al: LY294002 induces G0/G1 cell cycle arrest and apoptosis of cancer stem-like cells from human osteosarcoma via down-regulation of PI3K activity. Asian Pac J Cancer Prev. 13:3103–3107. 2012. View Article : Google Scholar : PubMed/NCBI
16	Zhang A, He S, Sun X, et al: Wnt5a promotes migration of human osteosarcoma cells by triggering a phosphatidylinositol-3 kinase/Akt signals. Cancer Cell Int. 14:152014. View Article : Google Scholar : PubMed/NCBI
17	Zhao H, Li M, Li L, et al: MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion and promotes apoptosis. PLoS One. 8:e835712013. View Article : Google Scholar
18	Kang J, Rychahou PG, Ishola TA, et al: N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma. Oncogene. 27:3999–4007. 2008. View Article : Google Scholar : PubMed/NCBI
19	Garcia V, Garcia JM, Silva J, et al: Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis. J Cancer Res Clin Oncol. 134:1165–1171. 2008. View Article : Google Scholar : PubMed/NCBI
20	Dillon RL and Muller WJ: Distinct biological roles for the akt family in mammary tumor progression. Cancer Res. 70:4260–4264. 2010. View Article : Google Scholar : PubMed/NCBI
21	Hassan B, Akcakanat A, Holder AM and Meric-Bernstam F: Targeting the PI3-kinase/Akt/mTOR signaling pathway. Surg Oncol Clin N Am. 22:641–664. 2013. View Article : Google Scholar : PubMed/NCBI
22	Liao CL, Lai KC, Huang AC, et al: Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase -2/-9, protein kinase B (PKB) and PKC signaling pathways. Food Chem Toxicol. 50:1734–1740. 2012. View Article : Google Scholar : PubMed/NCBI
23	Wu J, Wu X, Zhong D, et al: Short Hairpin RNA (shRNA) Ether à go-go 1 (Eag1) inhibition of human osteosarcoma angiogenesis via VEGF/PI3K/AKT signaling. Int J Mol Sci. 13:12573–12583. 2012. View Article : Google Scholar : PubMed/NCBI
24	van Maldegem AM, Bhosale A, Gelderblom HJ, Hogendoorn PC and Hassan AB: Comprehensive analysis of published phase I/II clinical trials between 1990–2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment. Clin Sarcoma Res. 2:52012. View Article : Google Scholar
25	Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med. 9:669–676. 2003. View Article : Google Scholar : PubMed/NCBI